Sintilimab Combined with Nanoparticle Albumin-Bound Paclitaxel-Based Chemotherapy in Severe Locally Advanced or Metastatic Squamous NSCLC Showed Good Efficacy and Safety: A Pilot Retrospective Analysis
Sintilimab combined with nab-PTX-based chemotherapy was effective and well tolerated in a small sample of severe lung squamous cell carcinoma population. This combination may offer a potential treatment option for these patients.
Authors
- Huaqiong Huang (ORCID: https://orcid.org/0000-0001-9017-7835)
- Yanxiong Mao (ORCID: https://orcid.org/0000-0002-7033-3383)
- Yonghong Zhong
- Xiaofang Fu
Institutions
- Second Affiliated Hospital of Zhejiang University (CN)
Publication Details
- Journal
- International Journal of Nanomedicine
- Published
- 2024-11-01
- DOI
- https://doi.org/10.2147/ijn.s484765
- Citations
- 3
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.85
Funders
- Natural Science Foundation of Zhejiang Province